|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM213143151 |
| 003 |
DE-627 |
| 005 |
20231224021004.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231224s2012 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1016/j.clim.2011.10.005
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n0710.xml
|
| 035 |
|
|
|a (DE-627)NLM213143151
|
| 035 |
|
|
|a (NLM)22094294
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Siberry, George K
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Increased risk of asthma and atopic dermatitis in perinatally HIV-infected children and adolescents
|
| 264 |
|
1 |
|c 2012
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 11.04.2012
|
| 500 |
|
|
|a Date Revised 18.03.2022
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a Copyright © 2011 Elsevier Inc. All rights reserved.
|
| 520 |
|
|
|a The incidence of asthma and atopic dermatitis (AD) was evaluated in HIV-infected (n = 451) compared to HIV-exposed (n = 227) but uninfected (HEU) children and adolescents by abstraction from clinical charts. Asthma was more common in HIV-infected compared to HEU children by clinical diagnosis (25% vs. 20%, p = 0.101), by asthma medication use, (31% vs. 22%, p = 0.012), and by clinical diagnosis and/or medication use, (34% vs. 25%, p = 0.012). HIV-infected children had a greater risk of asthma compared to HEU children (HR = 1.37, 95% CI: 1.01 to 1.86). AD was more common in HIV-infected than HEU children (20% vs. 12%, p = 0.009)) and children with AD were more likely to have asthma in both cohorts (41% vs. 29%, p = 0.010). HIV-infected children and adolescents in this study had an increased incidence of asthma and AD, a finding critical for millions of HIV-infected children worldwide
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Research Support, N.I.H., Extramural
|
| 650 |
|
4 |
|a Research Support, Non-U.S. Gov't
|
| 700 |
1 |
|
|a Leister, Erin
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jacobson, Denise L
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Foster, Samuel B
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Seage, George R
|c 3rd
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Lipshultz, Steven E
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Paul, Mary E
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Purswani, Murli
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Colin, Andrew A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Scott, Gwendolyn
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Shearer, William T
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Clinical immunology (Orlando, Fla.)
|d 1999
|g 142(2012), 2 vom: 15. Feb., Seite 201-8
|w (DE-627)NLM098196855
|x 1521-7035
|7 nnns
|
| 773 |
1 |
8 |
|g volume:142
|g year:2012
|g number:2
|g day:15
|g month:02
|g pages:201-8
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1016/j.clim.2011.10.005
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 142
|j 2012
|e 2
|b 15
|c 02
|h 201-8
|